<p><b>Abbreviations</b>: MyD88, myeloid differentiation primary response 88; TLR4, Toll-like receptor 4; ER, estrogen receptor; PR, progesterone receptor; HER-2, human epidermal growth factor receptor 2; HR, hazard ratio; CI, confidence interval.</p><p><b>P-value was calculated with a two-sided χ2 test.</b></p><p><b>Bold values denote P≤0.05.</b></p><p>Multivariate analysis of potential factors predicting disease-free survival and overall survival in breast cancer patients.</p
<p>Multivariate analysis of prognostic factors and adjuvant treatments for breast cancer patients.</...
Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians s...
Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians s...
<p><b>Abbreviations</b>: MyD88, myeloid differentiation primary response 88; TLR4, Toll-like recepto...
<p>Abbreviations: LN, lymph node; HER2, human epidermal growth factor receptor 2; TNBC, triple-negat...
<p>Abbreviations: LN, lymph node; EIC, extensive intraductal component; ER, oestrogen receptor; PR, ...
<p>TNM tumor-node-metastasis, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal g...
<p><b>Abbreviations</b>: BCSS, breast cancer-specific survival; RFS, recurrence/metastasis-free surv...
<p>Multivariate Analysis of Factors for Disease-free and Overall Survival in Primary Breast cancer.<...
<p>Abbreviations: HR = hazard ratio; CI = confidence interval; MTV = metabolic tumor volume.</p><p>M...
<p>Abbreviation: CCS <i>Cancer-specific survival</i>, CI <i>confidence interval</i>, ER <i>Estrogen ...
<p>Abbreviations: HR+/HER2-, hormone receptor-positive/human epidermal growth factor receptor 2-nega...
<p>Bold: shorter overall survival</p><p>Multivariate analysis of patient prognoses in metastatic bre...
<p>Abbreviations: HR, hazard ratio; CI, confidence interval; TNM, tumour node metastasis; OS, overal...
<p>Abbreviations: HR, hazard ratio; CI, confidence interval; TIL, tumor infiltrating lymphocyte; BMI...
<p>Multivariate analysis of prognostic factors and adjuvant treatments for breast cancer patients.</...
Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians s...
Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians s...
<p><b>Abbreviations</b>: MyD88, myeloid differentiation primary response 88; TLR4, Toll-like recepto...
<p>Abbreviations: LN, lymph node; HER2, human epidermal growth factor receptor 2; TNBC, triple-negat...
<p>Abbreviations: LN, lymph node; EIC, extensive intraductal component; ER, oestrogen receptor; PR, ...
<p>TNM tumor-node-metastasis, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal g...
<p><b>Abbreviations</b>: BCSS, breast cancer-specific survival; RFS, recurrence/metastasis-free surv...
<p>Multivariate Analysis of Factors for Disease-free and Overall Survival in Primary Breast cancer.<...
<p>Abbreviations: HR = hazard ratio; CI = confidence interval; MTV = metabolic tumor volume.</p><p>M...
<p>Abbreviation: CCS <i>Cancer-specific survival</i>, CI <i>confidence interval</i>, ER <i>Estrogen ...
<p>Abbreviations: HR+/HER2-, hormone receptor-positive/human epidermal growth factor receptor 2-nega...
<p>Bold: shorter overall survival</p><p>Multivariate analysis of patient prognoses in metastatic bre...
<p>Abbreviations: HR, hazard ratio; CI, confidence interval; TNM, tumour node metastasis; OS, overal...
<p>Abbreviations: HR, hazard ratio; CI, confidence interval; TIL, tumor infiltrating lymphocyte; BMI...
<p>Multivariate analysis of prognostic factors and adjuvant treatments for breast cancer patients.</...
Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians s...
Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians s...